I finished my research on Guess? Inc. [GES] this week, but I also got a concussion, thus I should have a report out by the end of this week. Meanwhile Guess was down sharply this week, and specifically Friday. This was due to a weaker outlook and worry about higher input costs from Gap. This will impact Guess only marginally, and I think represents a buying opportunity. For a full thesis on Guess, wait a week or so and I will put up a link. NRG was up again this week, albeit on low volume. I'm holding for the long-term. Astrazeneca was down a little bit this week in a possible top formation that would need confirmation by a strong pullback next week. Otherwise, this is needed consolidation. Eli Lilly was down this week, and may or may not be able to sustain levels above $37. Overall the market was down this week and seems to be direction-less going forward. This seems to represent consolidation on a monthly basis.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.